KYTHERA Biopharmaceuticals Inc (NASDAQ:KYTH)

Data as of Oct 01
 -0.12 / -0.37%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. The company's product candidate includes ATX-10 which is an injectable drug currently in Phase III clinical development for the reduction of submental fat. Its initial focus is on the facial aesthetics market, which comprises the majority of the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Calabasas, CA.

Contact Information

KYTHERA Biopharmaceuticals, Inc.
27200 West Agoura Road
Calabasas California 91301-5127
P:(818) 587-4500
Investor Relations:
(818) 587-4559



Mutual fund holders46.86%
Other institutional37.16%
Individual stakeholders33.66%

Top Executives

Keith R. LeonardPresident, Chief Executive Officer & Director
Jeffrey D. WebsterSenior Vice President-Operations
John W. SmitherChief Financial Officer
Serge LichtsteinerVice President-Research
Paul F. LizzulMedical Director

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.